Statistical inferences based on an adaptive progressive type-II censoring from exponentiated exponential distribution
-
Add time:09/03/2019 Source:sciencedirect.com
In this paper, the estimation problem (point and interval) is studied under the exponentiated exponential (EE) distribution based on an adaptive progressive type-II censoring scheme. In point estimation, the maximum likelihood estimates (MLE′s) and Bayes estimates (BE′s), based on squared error (SE) and linear exponential (LINEX) loss functions, are computed. Also, the approximate confidence intervals for the parameters of EE distribution are obtained. A comparison study is made between the BE′s and MLE′s using the estimated risks (ER′s) criterion. Finally, point and interval estimations of all parameters are studied based on a generated adaptive type-II progressive censoring sample from a real data set as illustrative example.
We also recommend Trading Suppliers and Manufacturers of Adaptic II (cas 111274-61-4). Pls Click Website Link as below: cas 111274-61-4 suppliers
Prev:Structural characterisation of adaptive facades in Europe - Part II: Validity of conventional experimental testing methods and key issues
Next:ReviewThe adaptive cycle: More than a metaphor) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Estimation of the inverse Weibull parameters under adaptive type-II progressive hybrid censoring scheme09/06/2019
- Estimation for the exponentiated Weibull model with adaptive Type-II progressive censored schemes09/05/2019
- ReviewThe adaptive cycle: More than a metaphor09/04/2019
- Structural characterisation of adaptive facades in Europe - Part II: Validity of conventional experimental testing methods and key issues09/02/2019
- Estimation of the inverted exponentiated Rayleigh Distribution Based on Adaptive Type II Progressive Hybrid Censored Sample09/01/2019
- Adaption and restoration of anammox biomass to Cd(II) stress: Performance, extracellular polymeric substance and microbial community08/31/2019
- Persisting enteropathy and disturbed adaptive mucosal immunity due to MHC class II deficiency08/30/2019
- Translational ToolboxPhase II Trials in Drug Development and Adaptive Trial Design08/29/2019


